Asia Pacific Advanced Therapy Medicinal Products Market Size, Share, Growth, and Industry Analysis, Type (Gene Therapy, Cell Therapy, Tissue Engineered Products), Application (Oncology, Rare Diseases, Cardiovascular Diseases), Regional Insights and Forecast to 2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Asia Pacific Advanced Therapy Medicinal Products Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Asia Pacific Advanced Therapy Medicinal Products Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Asia Pacific Advanced Therapy Medicinal Products Market, Type
   1. Introduction
      1. Market Size and Forecast, Type
   2. Gene Therapy
      1. Market Size and Forecast, By Region
   3. Cell Therapy
      1. Market Size and Forecast, By Region
   4. Tissue Engineered Products
      1. Market Size and Forecast, By Region
10. Asia Pacific Advanced Therapy Medicinal Products Market, Application
    1. Introduction
       1. Market Size and Forecast, Application
    2. Oncology
       1. Market Size and Forecast, By Region
    3. Rare Diseases
       1. Market Size and Forecast, By Region
    4. Cardiovascular Diseases
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. APAC
       1. Market Size and Forecast
          1. Type
             1. Gene Therapy
             2. Cell Therapy
             3. Tissue Engineered Products
          2. Application
             1. Oncology
             2. Rare Diseases
             3. Cardiovascular Diseases
       2. China
          1. Type
             1. Gene Therapy
             2. Cell Therapy
             3. Tissue Engineered Products
          2. Application
             1. Oncology
             2. Rare Diseases
             3. Cardiovascular Diseases
       3. South Korea
       4. Japan
       5. India
       6. Australia
       7. Singapore
       8. Taiwan
       9. South East Asia
       10. Rest of Asia-Pacific
12. Competitive Landscape, 2025
    1. Introduction
    2. Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. Novartis AG
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Gilead Sciences Inc.
    3. Takeda Pharmaceutical Company Limited
    4. Fujifilm Holdings Corporation
    5. Astellas Pharma Inc.
    6. Samsung Biologics
    7. Celltrion Inc.
    8. WuXi AppTec
    9. Lonza Group AG
    10. Mesoblast Limited
    11. Bluebird Bio Inc.
    12. CRISPR Therapeutics
    13. Sangamo Therapeutics